Guidance

The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on Magnetic resonance image-guided transcutaneous focused ultrasound for uterine fibroids

This document replaces previous guidance on Magnetic resonance image-guided transcutaneous focused ultrasound ablation for uterine fibroids (NICE interventional procedure guidance 231, September 2007).

Description

Uterine fibroids are non-cancerous (benign) growths that occur in the womb. They can cause heavy menstruation and reproductive problems. This procedure uses magnetic resonance imaging (MRI) to locate the fibroids and direct high-intensity ultrasound energy to destroy fibroid tissue, with the aim of reducing symptoms.

Coding recommendations

Q20.6 Focused ultrasound to lesion of uterus

Y53.7 Approach to organ under magnetic resonance imaging control

In addition the ICD-10 code from category D25.- Leiomyoma of uterus would be recorded.

 

Endorsing bodies

This interventional procedures guidance is endorsed by Healthcare Improvement Scotland as required by the Health and Social Care Act (2012).

  • National Institute for Health and Care Excellence (NICE)